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Role of Corticotrophin‐Releasing Factor in Alcohol Dependence
Introduction
The search for molecular mechanisms that contribute to the initiation and maintenance of alcohol addictive processes Bibli hi h
Methodology
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has become a major focus of the neuroscience of alcoholism. Both genetic and environmental factors are known to
contribute in the individual’s susceptibility to alcohol dependence or alcoholism. One of the most relevant
environmental risk factors for alcoholism is stress and the Corticotrophin‐Releasing Factor (CRF) plays a central role in
the modulation of the stress response. Hence, the following review aims:
• To examine the role of CRF and its receptor CRF1 in the etiology and maintenance of alcohol dependence.
• To search human polymorphisms in the CRF system involved in genetic susceptibility to become an alcoholic.
• To study the potential power of the CRF system as a target to treat alcoholic patients.
Methodology
ograp c researc :
• Search for scientific literature on Pubmed database.
• From November 2013 to March 2014.
• Keywords used: “CRF”, “addiction”, “alcohol dependence” or a combination of them.
• Papers and reviews selected according to the journal impact factor and the date of publication.
Conceptual framework: alcohol addiction
Alcohol addiction is a chronic relapsing disorder
characterized by a compulsion to seek and take alcohol,
loss of control in limiting intake and withdrawal
During the development of alcoholism two major psychiatric states
can be distinguished: the positive and the negative reinforcement.
syndrome in the absence of the drug.
Three recurrent and cyclical phases are commonly seen:
binge/intoxication, withdrawal/negative affect and
preoccupation/anticipation phase.
The “kindling”/stress hypothesis of alcoholism proposes that
the adaptive changes that accompany an escalating abuse of
alcohol interact with stress to maintain the pathology of alcoholism.
Positive reinforcement: euphoric effects of alcohol that lead to the
promotion of its consumption, primarily lead by the dopaminergic
mesolimbic pathway
Negative reinforcement: development of anxiety, depression and
other dysphoric psychiatric sequelae which can be caused by the
abrupt cessation of alcohol consumption
Figure 1. Alcohol abuse primarily disrupts the brain
reward and stress systems and causes a shift from
homeostasis to an allostatic state, the post dependent‐
state, term used to reflect the sum of within and
between‐system neuroadaptations that are induced as
an individual becomes dependent on alcohol and remain
Figure 2. There is a progression from positive
reinforcement to negative reinforcement during
the development of alcohol dependence (Koob
GF, 2013).
even in the absence of the drug.
CRF signaling CRF signaling in alcohol‐dependence
Alcohol, as most of the stressors, can activate HPA axis. This activation is CRF‐dependent. Specifically, alcohol acts
directly on CRF‐positive neurons of the PVN of the hypothalamus.
As alcohol consumption continues, the HPA axis becomes blunted, but
the repeated exposure of the brain to high levels of glucocorticoids can
“sensitize” the extra‐hypothalamic CRF systems, which are involved in
the dysphoric effects of alcohol withdrawal.
In terms of addiction, CRF is considered a pro‐stress and anti‐reward polypeptide.
Hypothalamic CRF‐positive neurons
mediate endocrine stress responses
trough activation of pituitary CRF1
receptors, whereas the behavioural
stress responses are largely
mediated by extra‐hypothalamic
CRF1 receptors primarily located in
the amygdala and BNST.
CRF release, as well as CRF1 receptor
levels, are increased in the amygdala and
drive excessive alcohol self‐administration
in dependent rodents, both during
withdrawal and long after withdrawal has
subsided.
As GABA and CRF are colocalized in about
half of the mostly GABAergic neurons in
the CeA, some data have implicated the
GABA system in the upregulation of CRF
system within the amygdala.
Positive
reinforcement
Figure 3. CRF drives the Hypothalamic‐Pituitary Adrenal (HPA) axis
by acting to release ACTH in the portal system of the pituitary.
Moreover, CRF activates the sympathetic system through actions
in the brainstem and mediates arousal and behavioural responses
to stressors through actions in the amygdala, other forebrain
regions, and central midbrain such as the ventral tegmental area
(Koob GF, 2010).
Figure 4. The first contribution of CRF to alcohol dependence is the HPA axis activation,
being glucocorticoids linked both to facilitation of reward (positive reinforcement) and
to sensitization of extra‐hypothalamic CRF systems, which contributes to a stress
component that drives from homeostasis to an allostatic state (negative reinforcement)
(Koob GF, 2010).
CRF involved in genetic susceptibility to become alcohol dependent
Alcohol dependence has an estimated heritability of 50‐60%, with many susceptibility loci contributing individually to a
small degree. Supporting the translational relevance of the genetic results in animal models, polymorphisms in human
CRF system as a major target to treat alcohol dependence
Blocking hyperactive signalling at CRF1 in individuals with a story of dependence or innate susceptibility to alcohol
dependence could inhibit heavy drinking and reduce the risk of relapse, the two main therapeutic objectives in
Negative
reinforcement
CRF system molecules have also been studied and associated with alcohol use phenotypes.
Crhr1 gene encodes CRF1 receptor and Crhbp gene encodes CRF‐binding protein, which moderates the ability of CRF to interact with its receptor.
Genetic association of CRF system polymorphisms to human alcohol phenotypes
Figure 5. Systemic administration of CRF1 antagonists (such as R121919)
attenuates both the heightened anxiety‐like behaviour and the escalated
alcohol self‐administration of dependent rodents at doses that do not alter
intake of non‐dependent animals (Heilig M et al., 2007).
alcoholism treatment.
Potentiate nociceptin‐CRF or neuropeptide Y‐CRF interactions may
also emerge as possible treatments of alcohol dependence due to
the ability of these two anti‐stress peptides to prevent and reverse
pre‐synaptic GABA release induced by CRF in CeA.
Conclusions
• The development of alcohol dependence is associated with neuroadaptive changes at functional, neurochemical
and structural levels.
• CRF contributes to alcohol dependence via:
‐ HPA axis activation (positive reinforcement).
‐ Extra‐hypothalamic CRF system recruitment primarily within the amygdala (negative reinforcement), which
contributes to a stress component that leads from homeostasis to an allostatic state.
• Targeting CRF signalling is emerging as a key approach to treat alcoholic patients for whom, due to experiential or
genetic reasons, stress and negative reinforcement play a major role in their alcohol dependence cycle.
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